WO2009037402A3 - Variants de hpiv-2, et leurs applications medicales - Google Patents

Variants de hpiv-2, et leurs applications medicales Download PDF

Info

Publication number
WO2009037402A3
WO2009037402A3 PCT/FR2008/001067 FR2008001067W WO2009037402A3 WO 2009037402 A3 WO2009037402 A3 WO 2009037402A3 FR 2008001067 W FR2008001067 W FR 2008001067W WO 2009037402 A3 WO2009037402 A3 WO 2009037402A3
Authority
WO
WIPO (PCT)
Prior art keywords
hpiv
variants
medical applications
group
hpiv2
Prior art date
Application number
PCT/FR2008/001067
Other languages
English (en)
Other versions
WO2009037402A9 (fr
WO2009037402A2 (fr
Inventor
Bruno Lina
Olivier Terrier
Danielle Francoise Thouvenot
Original Assignee
Centre Nat Rech Scient
Hospices Civils Lyon
Bruno Lina
Olivier Terrier
Danielle Francoise Thouvenot
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre Nat Rech Scient, Hospices Civils Lyon, Bruno Lina, Olivier Terrier, Danielle Francoise Thouvenot filed Critical Centre Nat Rech Scient
Priority to JP2010516542A priority Critical patent/JP5591697B2/ja
Priority to CA2694494A priority patent/CA2694494A1/fr
Priority to US12/669,607 priority patent/US8927701B2/en
Priority to EP08831374A priority patent/EP2170935A2/fr
Publication of WO2009037402A2 publication Critical patent/WO2009037402A2/fr
Publication of WO2009037402A3 publication Critical patent/WO2009037402A3/fr
Publication of WO2009037402A9 publication Critical patent/WO2009037402A9/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18611—Respirovirus, e.g. Bovine, human parainfluenza 1,3
    • C12N2760/18621—Viruses as such, e.g. new isolates, mutants or their genomic sequences

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

La présente demande est relative à un groupe phylogénique variant de HPIV2, plus particulièrement à un sous-groupe phylogénique variant de HPIV2. La demande propose des moyens pour le diagnostic de HPIV2, qui tiennent compte de ce groupe et de ce sous-groupe.
PCT/FR2008/001067 2007-07-19 2008-07-18 Variants de hpiv-2, et leurs applications medicales WO2009037402A2 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
JP2010516542A JP5591697B2 (ja) 2007-07-19 2008-07-18 Ｈｐｉｖ−２のバリアント及びそれらの医学的な適用
CA2694494A CA2694494A1 (fr) 2007-07-19 2008-07-18 Variants de hpiv-2, et leurs applications medicales
US12/669,607 US8927701B2 (en) 2007-07-19 2008-07-18 HPIV-2 variants and their medical applications
EP08831374A EP2170935A2 (fr) 2007-07-19 2008-07-18 Variants de hpiv-2, et leurs applications medicales

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0705235A FR2918995B1 (fr) 2007-07-19 2007-07-19 Variants de hpiv-2,et leurs applications medicales
FR0705235 2007-07-19

Publications (3)

Publication Number Publication Date
WO2009037402A2 WO2009037402A2 (fr) 2009-03-26
WO2009037402A3 true WO2009037402A3 (fr) 2009-05-14
WO2009037402A9 WO2009037402A9 (fr) 2010-02-18

Family

ID=39145194

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR2008/001067 WO2009037402A2 (fr) 2007-07-19 2008-07-18 Variants de hpiv-2, et leurs applications medicales

Country Status (6)

Country Link
US (1) US8927701B2 (fr)
EP (1) EP2170935A2 (fr)
JP (1) JP5591697B2 (fr)
CA (1) CA2694494A1 (fr)
FR (1) FR2918995B1 (fr)
WO (1) WO2009037402A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3057154A1 (fr) * 2017-03-24 2018-09-27 Gen-Probe Incorporated Compositions et procedes de detection ou quantification du virus parainfluenza

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1327691A2 (fr) * 2002-01-04 2003-07-16 Dr. Chip Biotechnology Incorporation Détection des virus respiratoires

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7250171B1 (en) * 1997-05-23 2007-07-31 United States Of America As Represented By The Dept. Of Health & Human Services Construction and use of recombinant parainfluenza viruses expressing a chimeric glycoprotein

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1327691A2 (fr) * 2002-01-04 2003-07-16 Dr. Chip Biotechnology Incorporation Détection des virus respiratoires

Non-Patent Citations (16)

* Cited by examiner, † Cited by third party
Title
AGUILAR JOSE C ET AL: "Detection and identification of human parainfluenza viruses 1, 2, 3, and 4 in clinical samples of pediatric patients by multiplex reverse transcription-PCR", JOURNAL OF CLINICAL MICROBIOLOGY, vol. 38, no. 3, March 2000 (2000-03-01), pages 1191 - 1195, XP002472202, ISSN: 0095-1137 *
DATABASE UniProt [online] 29 May 2007 (2007-05-29), "Fusion glycoprotein F0.", XP002472207, retrieved from EBI accession no. UNIPROT:A4Z4H4 Database accession no. A4Z4H4 *
DATABASE UniProt [online] 29 May 2007 (2007-05-29), "Fusion glycoprotein F0.", XP002472209, retrieved from EBI accession no. UNIPROT:A4Z4H6 Database accession no. A4Z4H6 *
DATABASE UniProt [online] 29 May 2007 (2007-05-29), "Fusion glycoprotein F0.", XP002472213, retrieved from EBI accession no. UNIPROT:A4Z4I0 Database accession no. A4Z4I0 *
DATABASE UniProt [online] 29 May 2007 (2007-05-29), "Hemagglutinin-neuraminidase.", XP002472208, retrieved from EBI accession no. UNIPROT:A4Z4H5 Database accession no. A4Z4H5 *
DATABASE UniProt [online] 29 May 2007 (2007-05-29), "Hemagglutinin-neuraminidase.", XP002472210, retrieved from EBI accession no. UNIPROT:A4Z4H7 Database accession no. A4Z4H7 *
DATABASE UniProt [online] 29 May 2007 (2007-05-29), "Hemagglutinin-neuraminidase.", XP002472211, retrieved from EBI accession no. UNIPROT:A4Z4H8 Database accession no. A4Z4H8 *
DATABASE UniProt [online] 29 May 2007 (2007-05-29), "Hemagglutinin-neuraminidase.", XP002472212, retrieved from EBI accession no. UNIPROT:A4Z4H9 Database accession no. A4Z4H9 *
DATABASE UniProt [online] 29 May 2007 (2007-05-29), "Hemagglutinin-neuraminidase.", XP002472214, retrieved from EBI accession no. UNIPROT:A4Z4I1 Database accession no. A4Z4I1 *
FAN J ET AL: "RAPID SIMULTANEOUS DIAGNOSIS OF INFECTIONS WITH RESPIRATORY SYNCYTIAL VIRUSES A AND B, INFLUENZA VIRUSES A AND B, AND HUMAN PARAINFLUENZA VIRUS TYPES 1, 2, AND 3 BY MULTIPLEX QUANTITATIVE REVERSE TRANSCRIPTION-POLYMERASE CHAIN REACTION-ENZYME HYBRIDIZATI", CLINICAL INFECTIOUS DISEASES, THE UNIVERSITY OF CHICAGO PRESS, CHICAGO, IL, US, vol. 26, 1998, pages 1397 - 1402, XP009022813, ISSN: 1058-4838 *
HIBBITTS SAM ET AL: "Development and evaluation of NucliSens(R) Basic Kit NASBA for diagnosis of parainfluenza virus infection with 'end-point' and 'real-time' detection.", JOURNAL OF VIROLOGICAL METHODS, vol. 108, no. 2, March 2003 (2003-03-01), pages 145 - 155, XP002472205, ISSN: 0166-0934 *
LIOLIOS LISA ET AL: "Comparison of a multiplex reverse transcription-PCR-enzyme hybridization assay with conventional viral culture and immunofluorescence techniques for the detection of seven viral respiratory pathogens", JOURNAL OF CLINICAL MICROBIOLOGY, vol. 39, no. 8, August 2001 (2001-08-01), pages 2779 - 2783, XP002472204, ISSN: 0095-1137 *
RAY R ET AL: "DISTINCT HEMAGGLUTININ AND NEURAMINIDASE EPITOPES INVOLVED IN ANTIGENIC VARIATION OF RECENT HUMAN PARAINFLUENZA VIRUS TYPE 2 ISOLATES", VIRUS RESEARCH, AMSTERDAM, NL, vol. 24, no. 1, 1 June 1992 (1992-06-01), pages 107 - 113, XP000647388, ISSN: 0168-1702 *
ROVIDA FRANCESCA ET AL: "Monoclonal antibodies versus reverse transcription-PCR for detection of respiratory viruses in a patient population with respiratory tract infections admitted to hospital", JOURNAL OF MEDICAL VIROLOGY, vol. 75, no. 2, February 2005 (2005-02-01), pages 336 - 347, XP002472206, ISSN: 0146-6615 *
SKIADOPOULOS MARIO H ET AL: "The genome length of human parainfluenza virus type 2 follows the rule of six, and recombinant viruses recovered from non-polyhexameric-length antigenomic cDNAs contain a biased distribution of correcting mutations.", JOURNAL OF VIROLOGY, vol. 77, no. 1, January 2003 (2003-01-01), pages 270 - 279, XP002472203, ISSN: 0022-538X *
TERRIER O ET AL: "Characterization of naturally occurring parainfluenza virus type 2 (hPIV-2) variants", JOURNAL OF CLINICAL VIROLOGY, ELSEVIER, AMSTERDAM, NL, vol. 43, no. 1, 1 September 2008 (2008-09-01), pages 86 - 92, XP024098939, ISSN: 1386-6532, [retrieved on 20080625] *

Also Published As

Publication number Publication date
US20110077170A1 (en) 2011-03-31
WO2009037402A9 (fr) 2010-02-18
US8927701B2 (en) 2015-01-06
WO2009037402A2 (fr) 2009-03-26
JP5591697B2 (ja) 2014-09-17
EP2170935A2 (fr) 2010-04-07
FR2918995B1 (fr) 2013-02-08
CA2694494A1 (fr) 2009-03-26
FR2918995A1 (fr) 2009-01-23
JP2010533484A (ja) 2010-10-28

Similar Documents

Publication Publication Date Title
WO2007142752A3 (fr) Dispositifs médicaux implantables composites en biocéramique-polymère
WO2009108856A3 (fr) Signatures de microarn associées à la leucémie lymphoïde chronique humaine (llc) et leurs utilisations
WO2008036206A3 (fr) Dispositifs médicaux implantables à base de composite copolymère-biocéramique
WO2008100805A3 (fr) Anticorps anti-robo4 et utilisations de ceux-ci
EP2667810A4 (fr) Instrument chirurgical ultrasonore, procédé chirurgical associé, et procédé de fabrication correspondant
WO2009109532A9 (fr) Utilisation de défensines contre la tuberculose
ZA200805939B (en) Azacyclyl-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments
IL204556A0 (en) (cyclopropyl-phenyl)-phenyl-oxalamides, method for the production thereof, and use of same as a medicament
WO2008066784A3 (fr) Expression de foxp3 par des cellules cancéreuses
WO2008089397A3 (fr) Marqueurs du cancer adrb2
EP2168677A4 (fr) Absorbant d'oxyde composite ferromanganique, son procédé de préparation, et son procédé d'utilisation
IL202674A0 (en) Genetic variants on chr 15q24 as markers for use in diagnosis, prognosis and treatment of exfoliation syndrome and glaucoma
EP2322680A4 (fr) Acier facilement usinable, sans pb et respectueux de l'environnement et son procédé de fabrication
IL193339A0 (en) Novel aminoalcohol-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments
WO2009007532A3 (fr) Utilisation d'une hemoglobine pour la preparation de pansements, et pansements ainsi prepares
WO2007144057A3 (fr) Carbone antimicrobien
IL218216A0 (en) Novel arylated camphenes, processes for their preparation and uses thereof
EP2088140A4 (fr) Composés dihydrazide, leur préparation et leurs utilisations
HK1120837A1 (en) Elastic interlining, method for its manufacture and use
WO2009053742A3 (fr) Nouveaux sels
WO2009077635A3 (fr) Composition anti-inflammatoire, anti-oedémateuse et anti-érythémateuse, procédé permettant d'obtenir ladite composition et utilisations de celle-ci
AP2012006302A0 (en) Anti-trypanosome therapeutic and diagnostic applications.
WO2009037402A3 (fr) Variants de hpiv-2, et leurs applications medicales
WO2009032978A3 (fr) Compositions et procédés pour diagnostiquer et traiter des infections des voies urinaires
AU2007905169A0 (en) Diagnostic and therapeutic protocols

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08831374

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: 2008831374

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2694494

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2010516542

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 12669607

Country of ref document: US